Studies have also shown that interleukin (IL)-6 released by GAMs can significantly enhance the permeability of the blood–brain barrier in glioma patients by activating the JAK-STAT3 pathway in endothelial cells and downregulating the level of intercellular connexins, which leads to the formation of vasogenic brain edema (20). Here, IL6 is linked to central nervous system cancer.